We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

674 hedge funds and large institutions have $39.7B invested in Allergan plc in 2014 Q2 according to their latest regulatory filings, with 103 funds opening new positions, 272 increasing their positions, 223 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 52

77% more call options, than puts

Call options by funds: $1.11B | Put options by funds: $627M

22% more repeat investments, than reductions

Existing positions increased: 272 | Existing positions reduced: 223

19% more capital invested

Capital invested by funds: $33.3B → $39.7B (+$6.35B)

15% more funds holding in top 10

Funds holding in top 10: 7384 (+11)

7% more funds holding

Funds holding: 628674 (+46)

Holders
674
Holders Change
+46
Holders Change %
+7.32%
% of All Funds
19.36%
Holding in Top 10
84
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+15.07%
% of All Funds
2.41%
New
103
Increased
272
Reduced
223
Closed
52
Calls
$1.11B
Puts
$627M
Net Calls
+$482M
Net Calls Change
+$56.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Connor, Clark & Lunn Investment Management (CC&L)
251
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$10.4M -$1.59M -7,700 -15%
RJA
252
Raymond James & Associates
Florida
$10.4M +$1.91M +9,243 +25%
EIM
253
ExxonMobil Investment Management
Texas
$10.1M -$27.5K -133 -0.3%
EAM
254
Edge Asset Management
Washington
$10M +$9.3M +44,920 New
IRF
255
IBM Retirement Fund
New York
$9.87M -$57.6K -278 -0.6%
TCM
256
TimesSquare Capital Management
New York
$9.86M -$487K -2,352 -5%
CA
257
Commerzbank Aktiengesellschaft
Germany
$9.67M -$647K -3,126 -7%
VKH
258
Virtu KCG Holdings
New York
$9.62M +$7.88M +38,078 +748%
LP
259
LMR Partners
United Kingdom
$9.6M +$8.91M +43,024 New
RFA
260
Reilly Financial Advisors
California
$9.56M -$657K -3,173 -7%
SIA
261
Sit Investment Associates
Minnesota
$9.41M +$2.49M +12,005 +40%
CCM
262
Century Capital Management
Massachusetts
$9.35M -$1.04M -5,036 -11%
RCM
263
Raptor Capital Management
Massachusetts
$9.21M +$8.55M +41,300 New
PNC Financial Services Group
264
PNC Financial Services Group
Pennsylvania
$9.1M -$653K -3,155 -7%
Neuberger Berman Group
265
Neuberger Berman Group
New York
$9.06M +$2.56M +12,372 +44%
DCM
266
Driehaus Capital Management
Illinois
$9.03M +$2.89M +13,940 +52%
CCM
267
Cadence Capital Management
Massachusetts
$8.99M +$8.35M +40,310 New
DekaBank Deutsche Girozentrale
268
DekaBank Deutsche Girozentrale
Germany
$8.97M -$5.44M -26,276 -40%
OPERF
269
Oregon Public Employees Retirement Fund
Oregon
$8.94M +$787K +3,800 +10%
GXMC
270
Global X Management Company
New York
$8.83M +$8.2M +39,580 New
BLM
271
Bennett Lawrence Management
New York
$8.6M +$314K +1,515 +4%
BA
272
Boston Advisors
Massachusetts
$8.55M +$6.91M +33,386 +672%
DWA
273
Dorsey Wright & Associates
California
$8.53M +$4.21M +20,329 +98%
DIA
274
Dana Investment Advisors
Wisconsin
$8.49M +$2.56M +12,355 +48%
SG Americas Securities
275
SG Americas Securities
New York
$8.45M -$26.1M -126,062 -77%

AGN Hedge Fund Activity: Q2 2014 in Review

674 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2014, worth a combined $39.7B — up 19% from $33.3B a quarter earlier.

Buyers outnumbered sellers: 103 funds opened new AGN positions and 52 closed out — a net gain of 51 holders — while 272 added to existing stakes and 223 trimmed.

The largest buyer was Jana Partners, adding an estimated $363M. The largest seller was York Capital Management Global Advisors, exiting entirely with an estimated $198M sold.

  • 674 institutional investors held Allergan plc (AGN) as of Q2 2014, up from 628 in Q1 2014.
  • Funds reported $39.7B of Allergan plc stock for Q2 2014, up 19% quarter-over-quarter.
  • 103 funds opened new Allergan plc positions in Q2 2014 and 52 closed out, a net change of +51 holders.
  • The largest Allergan plc buyer in Q2 2014 was Jana Partners, an estimated $363M added.
  • The largest Allergan plc seller in Q2 2014 was York Capital Management Global Advisors, an estimated $198M sold.

Based on aggregated 13F filings for Q2 2014.